MYC and osteosarcoma: In the field of osteosarcoma research, it was found that c-Myc was overexpressed in a high percentage of localized tumors and metastases and that higher c-Myc expression correlated significantly with recurrence and poor prognosis in patients with osteosarcoma [21, 22].